Jeffrey T. Walsh

2016

In 2016, Jeffrey T. Walsh earned a total compensation of $3.1M as Chief Financial and Strategy Officer at bluebird bio, a 41% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$187,800
Option Awards$1,822,792
Salary$375,000
Stock Awards$707,140
Other$5,250
Total$3,097,982

Walsh received $1.8M in option awards, accounting for 59% of the total pay in 2016.

Walsh also received $187.8K in non-equity incentive plan, $375K in salary, $707.1K in stock awards and $5.3K in other compensation.

Rankings

In 2016, Jeffrey T. Walsh's compensation ranked 3,050th out of 14,075 executives tracked by ExecPay. In other words, Walsh earned more than 78.3% of executives.

ClassificationRankingPercentile
All
3,050
out of 14,075
78th
Division
Manufacturing
1,058
out of 5,488
81st
Major group
Chemicals And Allied Products
310
out of 1,900
84th
Industry group
Drugs
225
out of 1,543
85th
Industry
Biological Products, Except Diagnostic Substances
48
out of 287
83rd
Source: SEC filing on April 21, 2017.

Walsh's colleagues

We found six more compensation records of executives who worked with Jeffrey T. Walsh at bluebird bio in 2016.

2016

Nick Leschly

bluebird bio

Chief Executive Officer

2016

Susanna High

bluebird bio

Chief Operating Officer

2016

David Davidson

bluebird bio

Chief Medical Officer

2016

Philip Gregory

bluebird bio

Chief Scientific Officer

2016

Jason Cole

bluebird bio

Chief Legal Officer

2016

James DeTore

bluebird bio

Chief Financial Officer

News

In-depth

You may also like